These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 6. 2-Indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones. Kelly TA; McNeil DW; Rose JM; David E; Shih CK; Grob PM J Med Chem; 1997 Jul; 40(15):2430-3. PubMed ID: 9240358 [TBL] [Abstract][Full Text] [Related]
8. The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors. Xu G; Micklatcher M; Silvestri MA; Hartman TL; Burrier J; Osterling MC; Wargo H; Turpin JA; Buckheit RW; Cushman M J Med Chem; 2001 Nov; 44(24):4092-113. PubMed ID: 11708913 [TBL] [Abstract][Full Text] [Related]
9. Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine. Alcaro S; Alteri C; Artese A; Ceccherini-Silberstein F; Costa G; Ortuso F; Bertoli A; Forbici F; Santoro MM; Parrotta L; Flandre P; Masquelier B; Descamps D; Calvez V; Marcelin AG; Perno CF; Sing T; Svicher V ChemMedChem; 2011 Dec; 6(12):2203-13. PubMed ID: 21953939 [TBL] [Abstract][Full Text] [Related]
10. N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1. Uckun FM; Mao C; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Venkatachalam TK Bioorg Med Chem Lett; 1999 Sep; 9(18):2721-6. PubMed ID: 10509923 [TBL] [Abstract][Full Text] [Related]
11. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402 [TBL] [Abstract][Full Text] [Related]
12. Structural optimization of N Monforte AM; De Luca L; Buemi MR; Agharbaoui FE; Pannecouque C; Ferro S Bioorg Med Chem; 2018 Feb; 26(3):661-674. PubMed ID: 29291935 [TBL] [Abstract][Full Text] [Related]
13. Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity. Campiani G; Morelli E; Fabbrini M; Nacci V; Greco G; Novellino E; Ramunno A; Maga G; Spadari S; Caliendo G; Bergamini A; Faggioli E; Uccella I; Bolacchi F; Marini S; Coletta M; Nacca A; Caccia S J Med Chem; 1999 Oct; 42(21):4462-70. PubMed ID: 10543890 [TBL] [Abstract][Full Text] [Related]
15. A dipyrido [2,3-b:3',2'-f]azepine analog of the HIV-1 reverse transcriptase inhibitor nevirapine. Dyatkin AB; Brickwood JR; Proudfoot JR Bioorg Med Chem Lett; 1998 Aug; 8(16):2169-72. PubMed ID: 9873507 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants. Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553 [TBL] [Abstract][Full Text] [Related]
17. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus. Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178 [TBL] [Abstract][Full Text] [Related]
18. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1. Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724 [TBL] [Abstract][Full Text] [Related]
19. Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitors. O'Meara JA; Yoakim C; Bonneau PR; Bös M; Cordingley MG; Déziel R; Doyon L; Duan J; Garneau M; Guse I; Landry S; Malenfant E; Naud J; Ogilvie WW; Thavonekham B; Simoneau B J Med Chem; 2005 Aug; 48(17):5580-8. PubMed ID: 16107158 [TBL] [Abstract][Full Text] [Related]
20. Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants. Frey KM; Puleo DE; Spasov KA; Bollini M; Jorgensen WL; Anderson KS J Med Chem; 2015 Mar; 58(6):2737-45. PubMed ID: 25700160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]